Traws Pharma (TRAW)
Traws Pharma on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on Nasdaq.
686K
Short interest
settlement 2026-10-15
3.7
Days to cover
+2.7 days vs prior
39.2%
Short share of volume
2026-11-02
20,197
Fails to deliver
settlement 2026-10-14
Thu 12 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in TRAW is 685,721 shares, up 73,505 shares over the last month. Over the last 48 readings it ranged from 6,897 shares (13 December 2024) to 1,671,345 shares (15 May 2026). At the reported average volume of 185K shares a day that is 3.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/traw" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 685,721 | -0.7% | 184,550 | 3.72 |
| 2026-09-30 | 690,685 | +12.8% | 2,784,333 | 1.00 |
| 2026-09-15 | 612,216 | -3.4% | 71,075 | 8.61 |
| 2026-08-31 | 633,423 | +1.6% | 104,806 | 6.04 |
| 2026-08-14 | 623,760 | -0.5% | 97,552 | 6.39 |
| 2026-07-31 | 627,168 | -10.4% | 112,915 | 5.55 |
| 2026-07-15 | 699,850 | -28.6% | 183,308 | 3.82 |
| 2026-06-30 | 980,144 | -13.6% | 324,608 | 3.02 |
| 2026-06-15 | 1,134,900 | -17.5% | 700,289 | 1.62 |
| 2026-05-29 | 1,375,032 | -17.7% | 706,489 | 1.95 |
| 2026-05-15 | 1,671,345 | +198.4% | 10,790,912 | 1.00 |
| 2026-04-30 | 560,036 | +38.1% | 314,476 | 1.78 |
| 2026-04-15 | 405,599 | -1.5% | 197,587 | 2.05 |
| 2026-03-31 | 411,637 | -9.9% | 46,909 | 8.78 |
| 2026-03-13 | 456,663 | -12.2% | 104,727 | 4.36 |
| 2026-02-27 | 519,827 | -1.3% | 126,382 | 4.11 |
| 2026-02-13 | 526,505 | +4.1% | 135,200 | 3.89 |
| 2026-01-30 | 505,708 | -4.9% | 390,883 | 1.29 |
| 2026-01-15 | 531,738 | +106.1% | 355,149 | 1.50 |
| 2025-12-31 | 257,978 | +46.9% | 551,009 | 1.00 |
| 2025-12-15 | 175,604 | -39.8% | 200,167 | 1.00 |
| 2025-11-28 | 291,860 | +293.6% | 235,332 | 1.24 |
| 2025-11-14 | 74,142 | +37.0% | 922,674 | 1.00 |
| 2025-10-31 | 54,098 | -27.4% | 162,618 | 1.00 |
| 2025-10-15 | 74,502 | -44.7% | 390,746 | 1.00 |
| 2025-09-30 | 134,747 | +12.3% | 65,663 | 2.05 |
| 2025-09-15 | 119,973 | +16.9% | 114,460 | 1.05 |
| 2025-08-29 | 102,595 | -37.0% | 94,166 | 1.09 |
| 2025-08-15 | 162,903 | +68.6% | 187,058 | 1.00 |
| 2025-07-31 | 96,639 | -36.4% | 71,762 | 1.35 |
| 2025-07-15 | 151,953 | -33.9% | 70,116 | 2.17 |
| 2025-06-30 | 229,888 | -35.7% | 143,768 | 1.60 |
| 2025-06-13 | 357,548 | +273.5% | 6,674,305 | 1.00 |
| 2025-05-30 | 95,720 | +28.1% | 190,619 | 1.00 |
| 2025-05-15 | 74,699 | +1.0% | 171,838 | 1.00 |
| 2025-04-30 | 73,982 | -3.8% | 76,490 | 1.00 |
| 2025-04-15 | 76,884 | -11.8% | 43,883 | 1.75 |
| 2025-03-31 | 87,209 | +14.3% | 46,094 | 1.89 |
| 2025-03-14 | 76,309 | -55.7% | 199,969 | 1.00 |
| 2025-02-28 | 172,313 | -36.2% | 64,002 | 2.69 |
| 2025-02-14 | 270,196 | +79.2% | 32,372 | 8.35 |
| 2025-01-31 | 150,793 | -12.3% | 83,947 | 1.80 |
| 2025-01-15 | 171,871 | +21.1% | 207,974 | 1.00 |
| 2024-12-31 | 141,916 | +1957.7% | 2,837,718 | 1.00 |
| 2024-12-13 | 6,897 | -10.5% | 6,189 | 1.11 |
| 2024-11-29 | 7,708 | -25.5% | 7,416 | 1.04 |
| 2024-11-15 | 10,350 | +40.1% | 8,220 | 1.26 |
| 2024-10-31 | 7,389 | -24.1% | 10,777 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of TRAW volume is 39.2%, up 0.2 points over the last five sessions. Over the last 30 readings it ranged from 1.8% (29 October 2026) to 57.0% (20 October 2026). The latest reading is 13.0 points above the 30-session average of 26.2%, on 48K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 19K | 48K | 39.2% | 0 |
| 2026-10-30 | 37K | 98K | 37.8% | 23 |
| 2026-10-29 | 10K | 567K | 1.8% | 184 |
| 2026-10-28 | 3K | 11K | 25.8% | 0 |
| 2026-10-27 | 4K | 65K | 6.5% | 0 |
| 2026-10-26 | 6K | 15K | 39.0% | 0 |
| 2026-10-23 | 14K | 58K | 23.7% | 0 |
| 2026-10-22 | 11K | 31K | 35.7% | 8,184 |
| 2026-10-21 | 6K | 70K | 8.7% | 0 |
| 2026-10-20 | 27K | 47K | 57.0% | 0 |
| 2026-10-19 | 3K | 45K | 7.2% | 400 |
| 2026-10-16 | 38K | 230K | 16.7% | 0 |
| 2026-10-15 | 6K | 19K | 33.2% | 0 |
| 2026-10-14 | 14K | 43K | 31.9% | 0 |
| 2026-10-13 | 8K | 29K | 29.1% | 1,401 |
| 2026-10-12 | 17K | 118K | 14.1% | 0 |
| 2026-10-09 | 27K | 105K | 25.5% | 728 |
| 2026-10-08 | 6K | 41K | 14.5% | 246 |
| 2026-10-07 | 25K | 60K | 41.9% | 0 |
| 2026-10-06 | 7K | 57K | 12.7% | 0 |
| 2026-10-05 | 4K | 81K | 4.9% | 0 |
| 2026-10-02 | 14K | 50K | 27.6% | 0 |
| 2026-10-01 | 10K | 41K | 24.1% | 0 |
| 2026-09-30 | 29K | 149K | 19.5% | 0 |
| 2026-09-29 | 56K | 191K | 29.3% | 0 |
| 2026-09-28 | 19K | 63K | 29.9% | 0 |
| 2026-09-25 | 99K | 334K | 29.5% | 1,544 |
| 2026-09-24 | 10.6M | 19.5M | 54.4% | 81,486 |
| 2026-09-23 | 8K | 24K | 33.6% | 0 |
| 2026-09-22 | 19K | 62K | 31.3% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in TRAW is 20,197 shares, down 6,057 shares over the last settlement date. Over the last 30 readings it ranged from 7 shares (31 July 2026) to 81,485 shares (25 September 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 20,197 | $0.41 | $8K |
| 2026-10-13 | 26,254 | $0.42 | $11K |
| 2026-10-09 | 8,524 | $0.48 | $4K |
| 2026-10-08 | 4,878 | $0.48 | $2K |
| 2026-10-07 | 639 | $0.52 | $332 |
| 2026-10-05 | 3,294 | $0.57 | $2K |
| 2026-10-02 | 35 | $0.55 | $19 |
| 2026-09-30 | 907 | $0.63 | $571 |
| 2026-09-29 | 122 | $0.58 | $71 |
| 2026-09-28 | 1,116 | $0.56 | $625 |
| 2026-09-25 | 81,485 | $0.56 | $46K |
| 2026-09-24 | 861 | $0.50 | $431 |
| 2026-09-23 | 2,240 | $0.50 | $1K |
| 2026-09-22 | 8,951 | $0.50 | $4K |
| 2026-09-14 | 533 | $0.56 | $298 |
| 2026-09-10 | 1,012 | $0.54 | $546 |
| 2026-09-04 | 1,482 | $0.56 | $830 |
| 2026-09-02 | 7 | $0.59 | $4 |
| 2026-08-27 | 3,078 | $0.60 | $2K |
| 2026-08-14 | 11,898 | $0.60 | $7K |
| 2026-08-13 | 1,537 | $0.53 | $815 |
| 2026-08-11 | 1,321 | $0.54 | $713 |
| 2026-08-07 | 1,570 | $0.54 | $848 |
| 2026-08-05 | 7,712 | $0.55 | $4K |
| 2026-08-04 | 14 | $0.47 | $7 |
| 2026-07-31 | 7 | $0.44 | $3 |
| 2026-07-29 | 30 | $0.51 | $15 |
| 2026-07-24 | 10 | $0.52 | $5 |
| 2026-07-17 | 22 | $0.66 | $15 |
| 2026-07-15 | 1,351 | $0.70 | $946 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for TRAW in the last 90 days. The most recent filings are listed below. Latest filing: OrbiMed Capital GP VIII LLC (TenPercentOwner) on 2026-04-16.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-04-16 | OrbiMed Capital GP VIII LLC | TenPercentOwner | Buy | 598K | $1.67 | $998K | 1.2M |
| 2026-04-16 | ORBIMED ADVISORS LLC | 10% owner | Buy | 598K | $1.67 | $998K | 1.2M |
| 2025-12-12 | Shoemaker Mary Teresa | Director | Grant | 6K | $0.00 | $0 | 6K |
| 2025-12-12 | Savchuk Nikolay | Chief Operating Officer | Grant | 16K | $0.00 | $0 | 151K |
| 2025-12-12 | STOVER JACK E | Director | Grant | 6K | $0.00 | $0 | 6K |
| 2025-12-12 | Redfield Robert | Chief Medical Officer | Grant | 16K | $0.00 | $0 | 114K |
| 2025-12-12 | Pauza Charles David | Chief Science Officer Virology | Grant | 18K | $0.00 | $0 | 116K |
| 2025-12-12 | Leaman John Harold | Director | Grant | 4K | $0.00 | $0 | 4K |
| 2025-12-12 | Dukes Iain D. | Chief Executive Officer | Grant | 37K | $0.00 | $0 | 171K |
| 2025-12-12 | Clarke Trafford | Director | Grant | 6K | $0.00 | $0 | 6K |
| 2025-12-12 | CAUTREELS WERNER | Director | Grant | 5K | $0.00 | $0 | 109K |
| 2025-12-12 | Parker Charles Nolan | Chief Financial Officer | Grant | 15K | $0.00 | $0 | 15K |
| 2025-04-02 | Savchuk Nikolay | Chief Operating Officer | Other transaction | 606K | price not stated in the filing | not stated | 0 |
| 2025-02-18 | CAUTREELS WERNER | Chief Executive Officer | Exercise or conversion | 96K | $0.01 | $963 | 104K |
| 2024-06-18 | Guerin Mark Patrick | CFO | Tax withholding | 2K | $0.47 | $1K | 39K |
| 2024-06-10 | Guerin Mark Patrick | CFO | Exercise or conversion | 6K | price not stated in the filing | not stated | 41K |
| 2024-04-01 | Savchuk Nikolay | Chief Operating Officer | Grant | 68K | price not stated in the filing | not stated | 134K |
| 2024-04-01 | Dukes Iain D. | Executive Chairman | Grant | 68K | price not stated in the filing | not stated | 134K |
| 2024-04-01 | Dukes Iain D. | Executive Chairman | Grant | 67K | price not stated in the filing | not stated | 67K |
| 2024-04-01 | Dukes Iain D. | Executive Chairman | Grant | 68K | price not stated in the filing | not stated | 134K |
| 2024-04-01 | Dukes Iain D. | Executive Chairman | Grant | 1.6M | price not stated in the filing | not stated | 1.6M |
| 2024-04-01 | Savchuk Nikolay | Chief Operating Officer | Grant | 68K | price not stated in the filing | not stated | 134K |
| 2024-04-01 | Savchuk Nikolay | Chief Operating Officer | Grant | 67K | price not stated in the filing | not stated | 67K |
| 2024-04-01 | Savchuk Nikolay | Chief Operating Officer | Grant | 1.6M | price not stated in the filing | not stated | 1.6M |
| 2024-04-01 | Savchuk Nikolay | Chief Operating Officer | Grant | 886K | price not stated in the filing | not stated | 886K |
| 2024-04-01 | CAUTREELS WERNER | Chief Executive Officer | Grant | 200K | price not stated in the filing | not stated | 200K |
| 2024-04-01 | Pauza Charles David | Chief Science Officer Virology | Grant | 98K | price not stated in the filing | not stated | 98K |
| 2024-04-01 | Redfield Robert | Acting Chief Medical Officer | Grant | 98K | price not stated in the filing | not stated | 98K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON10 holders report 5% or more of TRAW in their latest filing, 2 on Schedule 13D (active intent). The largest reported stake is ORBIMED ADVISORS LLC at 11.9% of the class (1,876,198 shares), filed 2026-05-05 for an event on 2026-04-16.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 4 | Squadron Master Fund LPpartnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | Squadron Capital Management LLCinvestment adviser, parent holding company | 0 | 0.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | Matthew Sesterhennparent holding company, individual | 0 | 0.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | William Blankparent holding company, individual | 0 | 0.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Ikarian Capital, LLCinvestment adviser | 1.6M | 9.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Neil Shahrestaniindividual, parent holding company | 1.6M | 9.5% | 2026-06-30 |
| 2026-08-14 | 13G | Sirenia Capital Management LPinvestment adviser, partnership | 6.6M | 9.9% | 2026-06-30 |
| 2026-08-14 | 13G | Alex Silversteinparent holding company, individual | 6.6M | 9.9% | 2026-06-30 |
| 2026-08-12 | 13G/Ano. 1 | Adage Capital Management, L.P.investment adviser, partnership | 730K | 4.8% | 2026-06-30 |
| 2026-08-12 | 13G/Ano. 1 | Robert Atchinsonparent holding company, individual | 730K | 4.8% | 2026-06-30 |
| 2026-08-12 | 13G/Ano. 1 | Phillip Grossparent holding company, individual | 730K | 4.8% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 3 | Joseph Edelmanindividual | 980K | 6.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Perceptive Life Sciences Master Fund, Ltd.corporation | 980K | 6.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Perceptive Advisors LLCinvestment adviser | 980K | 6.1% | 2026-03-31 |
| 2026-05-05 | 13D/Ano. 3 | ORBIMED ADVISORS LLCinvestment adviser | 1.9M | 11.9% | 2026-04-16 |
| 2026-05-05 | 13D/Ano. 3 | OrbiMed Capital GP VIII LLCother entity | 1.9M | 11.9% | 2026-04-16 |
| 2026-02-11 | 13G/Ano. 1 | Ayrton Capital LLCinvestment adviser, corporation | 343K | 4.3% | 2025-12-31 |
| 2026-02-11 | 13G/Ano. 1 | Waqas Khatriindividual | 343K | 4.3% | 2025-12-31 |
| 2026-02-11 | 13G/Ano. 1 | Alto Opportunity Master Fund, SPC - Segregated Master Portfolio Bcorporation | 343K | 4.3% | 2025-12-31 |
| 2026-01-16 | 13G | Chernett Joreyindividual | 543K | 6.8% | 2026-01-14 |
What this page is
Traws Pharma in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Traws Pharma (TRAW), SEC CIK 1130598, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-04-16.JSON and CSV
- Company record
- EDGAR filing index for CIK 1130598Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
- SYRESpyre Therapeutics
- SYYSysco
- TAT&T
- TAPMolson Coors
- TCOMTrip.com Group
- TDToronto-Dominion Bank
- TDGTransDigm Group
- TDYTeledyne Technologies
Datasets
Frequently Asked Questions
How much of TRAW is sold short?
What is TRAW's daily short volume?
Does TRAW have fails to deliver?
Are TRAW insiders buying or selling?
Who owns 5% or more of TRAW?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.